High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This is a standard of care document, outlining the therapy for children with high risk
neuroblastoma who are not eligible for Children's Oncology Group (COG) studies.